Literature DB >> 15188501

Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.

Guo-Xin Zhang1, Yan-Hong Gu, Zhi-Quan Zhao, Shun-Fu Xu, Hong-Ji Zhang, Hong-Di Wang, Bo Hao.   

Abstract

AIM: To detect the telomerase activity and c-Myc expression in gastric diseases and to examine the relation between these values and Helicobacter pylori (H pylori) as a risk factor for gastric cancer.
METHODS: One hundred and seventy-one gastric samples were studied to detect telomerase activity using a telomerase polymerase chain reaction enzyme linked immunosorbent assay (PCR-ELISA), and c-Myc expression using immunohistochemistry.
RESULTS: The telomerase activity and c-Myc expression were higher in cancers (87.69% and 61.54%) than in noncancerous tissues. They were higher in chronic atrophic gastritis with severe intestinal metaplasia (52.38% and 47.62%) than in chronic atrophic gastritis with mild intestinal metaplasia (13.33% and 16.67%). In chronic atrophic gastritis with severe intestinal metaplasia, the telomerase activity and c-Myc expression were higher in cases with H pylori infection (67.86% and 67.86%) than in those without infection (21.43% and 7.14%). c-Myc expression was higher in gastric cancer with H pylori infection (77.27%) than in that without infection (28.57%). The telomerase activity and c-Myc expression were coordinately up-regulated in H pylori infected gastric cancer and chronic atrophic gastritis with severe intestinal metaplasia.
CONCLUSION: H pylori infection may influence both telomerase activity and c-Myc expression in gastric diseases, especially in chronic atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188501      PMCID: PMC4572264          DOI: 10.3748/wjg.v10.i12.1759

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.

Authors:  T I Kuschak; C Taylor; E McMillan-Ward; S Israels; D W Henderson; J F Mushinski; J A Wright; S Mai
Journal:  Gene       Date:  1999-10-01       Impact factor: 3.688

2.  Helicobacter pylori infection induces telomerase activity in premalignant lesions.

Authors:  H Kameshima; A Yagihashi; T Yajima; N Watanabe; Y Ikeda
Journal:  Am J Gastroenterol       Date:  1999-02       Impact factor: 10.864

3.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter.

Authors:  Y S Cong; J Wen; S Bacchetti
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

4.  Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues.

Authors:  H Kameshima; A Yagihashi; T Yajima; D Kobayashi; R Denno; K Hirata; N Watanabe
Journal:  World J Surg       Date:  2000-10       Impact factor: 3.352

5.  Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

Authors:  H Kojima; O Yokosuka; F Imazeki; H Saisho; M Omata
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

Review 6.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

7.  Telomerase activity: a prevalent marker of malignant human prostate tissue.

Authors:  H J Sommerfeld; A K Meeker; M A Piatyszek; G S Bova; J W Shay; D S Coffey
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

8.  c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis.

Authors:  Thierry Fest; Virginie Mougey; Véronique Dalstein; Marlon Hagerty; Danielle Milette; Santiago Silva; Sabine Mai
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

9.  Telomerase activity in human bladder cancer.

Authors:  Y Lin; H Miyamoto; K Fujinami; H Uemura; M Hosaka; Y Iwasaki; Y Kubota
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531

10.  Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.

Authors:  H Tahara; H Kuniyasu; H Yokozaki; W Yasui; J W Shay; T Ide; E Tahara
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531

View more
  11 in total

1.  Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Aline-Damaceno Seabra; Andre-Salim Khayat; Elizabeth Suchi Chen; Samia Demachki; Paulo Pimentel Assumpção; Mario Henrique Girão Faria; Silvia Helena Barem Rabenhorst; Márcia Valéria Pitombeira Ferreira; Marília de Arruda Cardoso Smith; Rommel-Rodríguez Burbano
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

2.  Differential expression of MYC in H. pylori-related intestinal and diffuse gastric tumors.

Authors:  Isabelle Joyce de Lima Silva-Fernandes; Markênia Kélia Santos Alves; Valeska Portela Lima; Marcos Antônio Pereira de Lima; Marcos Aurélio Pessoa Barros; Márcia Valéria Pitombeira Ferreira; Silvia Helena Barem Rabenhorst
Journal:  Virchows Arch       Date:  2011-05-03       Impact factor: 4.064

Review 3.  Glioma: what is the role of c-Myc, hsp90 and telomerase?

Authors:  A Shervington; N Cruickshanks; H Wright; R Atkinson-Dell; R Lea; G Roberts; L Shervington
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

Review 4.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling.

Authors:  Jing Liu; Wenxin Feng; Min Liu; Hanyu Rao; Xiaoxue Li; Yan Teng; Xiao Yang; Jin Xu; Weiqiang Gao; Li Li
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

6.  hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions.

Authors:  Tanielly Cristina Raiol Silva; Mariana Ferreira Leal; Danielle Queiroz Calcagno; Carolina Rosal Teixeira de Souza; André Salim Khayat; Ney Pereira Carneiro dos Santos; Raquel Carvalho Montenegro; Silvia Helena Barem Rabenhorst; Mayara Quaresma Nascimento; Paulo Pimentel Assumpção; Marília de Arruda Cardoso Smith; Rommel Rodríguez Burbano
Journal:  BMC Gastroenterol       Date:  2012-07-06       Impact factor: 3.067

Review 7.  Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma.

Authors:  Mohammad Shadifar; Ramin Ataee; Amin Ataie; Ali Morad Heydari Gorgi; Nafiseh Nasri Nasrabadi; Somayyeh Nouri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

8.  Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

Authors:  Chia Huey Ooi; Tatiana Ivanova; Jeanie Wu; Minghui Lee; Iain Beehuat Tan; Jiong Tao; Lindsay Ward; Jun Hao Koo; Veena Gopalakrishnan; Yansong Zhu; Lai Ling Cheng; Julian Lee; Sun Young Rha; Hyun Cheol Chung; Kumaresan Ganesan; Jimmy So; Khee Chee Soo; Dennis Lim; Weng Hoong Chan; Wai Keong Wong; David Bowtell; Khay Guan Yeoh; Heike Grabsch; Alex Boussioutas; Patrick Tan
Journal:  PLoS Genet       Date:  2009-10-02       Impact factor: 5.917

9.  Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.

Authors:  Douglas B Stairs; Hiroshi Nakagawa; Andres Klein-Szanto; Shukriyyah D Mitchell; Debra G Silberg; John W Tobias; John P Lynch; Anil K Rustgi
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

10.  The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer.

Authors:  Jung Hwan Yoon; Yong Gyu Park; Suk Woo Nam; Won Sang Park
Journal:  Cancer Med       Date:  2019-08-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.